Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.55 USD | -4.93% | +3.58% | +14.92% |
09/05 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
08/05 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.92% | 564M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Transcript : IGM Biosciences, Inc. Presents at Bank of America 2022 Virtual Biotech SMID Cap Conference, Dec-08-2022 02